Pneumonia News and Research

RSS
Pneumonia is a leading cause of death and hospitalization, costing health care systems billions of dollars and an estimated 600,000 adult deaths worldwide each year. Pneumococcal disease is caused by the bacterium Streptococcus pneumoniae and the term describes a group of illnesses, including invasive infections, such as bacteremia/sepsis and meningitis, as well as pneumonia and upper respiratory tract infections. Although all age groups may be affected, the highest rate of pneumococcal disease occurs in young children and older adults. In addition, persons suffering from a wide range of chronic conditions (eg, diabetes, cardiovascular disease) and immune deficiencies are at increased risk.
New Virus Targets Dormant Bacteria, Boosting Antibiotic Power

New Virus Targets Dormant Bacteria, Boosting Antibiotic Power

Novel Bacterial Protein can Prolong Cell Longevity by Acting Directly on Mitochondria

Novel Bacterial Protein can Prolong Cell Longevity by Acting Directly on Mitochondria

Genomic Surveillance Shows Antibiotic Resistance in Ghana Driven by Clinical Use of Antibiotics

Genomic Surveillance Shows Antibiotic Resistance in Ghana Driven by Clinical Use of Antibiotics

Understanding How Antibiotic Resistance Occurs in Pneumonia

Understanding How Antibiotic Resistance Occurs in Pneumonia

Analyzing the First Vaccine Against Respiratory Syncytial Virus in Many Older Adults

Analyzing the First Vaccine Against Respiratory Syncytial Virus in Many Older Adults

Nasal Swab Proves to Determine the Effectiveness of Antibiotics

Nasal Swab Proves to Determine the Effectiveness of Antibiotics

Study Provides More Treatment Options for Severe COVID-19

Study Provides More Treatment Options for Severe COVID-19

Study Characterizes the Properties of MAIT Cells in Mouse Lung

Study Characterizes the Properties of MAIT Cells in Mouse Lung

Targeting Respiratory Viral Infections with a New Immunotherapy Treatment

Targeting Respiratory Viral Infections with a New Immunotherapy Treatment

Researchers Reveal Dual Nature of Beneficial Bacteria UD1022

Researchers Reveal Dual Nature of Beneficial Bacteria UD1022

Organoid Platform Could Help Reduce the Time for Developing New Conjugate Vaccines

Organoid Platform Could Help Reduce the Time for Developing New Conjugate Vaccines

Study reports a new target to fight against antibiotic-resistant pneumonia

Study reports a new target to fight against antibiotic-resistant pneumonia

Fomepizole may reduce disease severity in the lungs of mice with bacterial pneumonia

Fomepizole may reduce disease severity in the lungs of mice with bacterial pneumonia

Effective and faster methodology detects RNA viruses based on the triplex-forming probe technology

Effective and faster methodology detects RNA viruses based on the triplex-forming probe technology

New genetic condition that raises vulnerability to opportunistic infections

New genetic condition that raises vulnerability to opportunistic infections

Studying the association between gut microbe and Parkinson’s disease

Studying the association between gut microbe and Parkinson’s disease

Exploring behavioral variation in a non-captive animal population

Exploring behavioral variation in a non-captive animal population

Combating antibiotic-resistant bacteria with new drug

Combating antibiotic-resistant bacteria with new drug

Molecular responses of Pseudomonas aeruginosa to hydroquinine

Molecular responses of Pseudomonas aeruginosa to hydroquinine

Hydroquinine inhibits and kills several strains of clinically important bacteria

Hydroquinine inhibits and kills several strains of clinically important bacteria